chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Asymptomatic COVID-19, Atrial fibrillation, Blood loss anaemia, Cardiac telemetry abnormal
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Diarrhoea, Diarrhoea infectious, Electrocardiogram abnormal, Endotracheal intubation
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erosive oesophagitis, Foreign travel, Haemodynamic instability, Haemoglobin decreased, Haemostasis
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Hypotension, Intensive care, Oedema peripheral, Oesophageal ulcer
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oesophageal ulcer haemorrhage, Oesophagogastroduodenoscopy abnormal, Platelet transfusion, Red blood cell transfusion, SARS-CoV-2 test positive
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Shock haemorrhagic, Sinus rhythm, Supraventricular extrasystoles, Transfusion, Upper gastrointestinal haemorrhage
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vascular cauterisation
Clinical narrative: Patient up to date on COVID vaccinations, last dose 09/23/21, who admitted the hospital with an upper GI bleed.  Incidental COVID finding (asymptomatic for respiratory issues during stay) during admission testing.  Provider discharge note below:  "75 YO male with h/oCABG, AV repair (2008), HTN, HLD, who was admitted 4/18 after presenting with UGIB. He was hemodynamically unstable and was treated initially in the CCU where intubation/pressors were required (4/19-4/21). EGD  4/19 showed erosive esophagitis and in the distal esophagus there was an ulcer with oozing vessel. This was treated with epinephrine injection and cauterization. Second look EGD 4/21 was done and showed no evidence of active bleeding.  He was extubated uneventfully following 2nd EGD. He was able to be restarted on his PTA antihypertensives and transferred to general floor 4/22.  diet was advanced to a soft diet which he tolerated well there was no evidence of any further bleeding.  Hemoglobin was stable greater than 7. Discharged home in good condition with plan as below.   UGIB - erosive esophagitis in distal esophagus, with ulcer and oozing vessel; s/p epinephrine injection and cauterization with hemostasis.   - Continue PPI BID x 8 weeks  - Carafate QID x4 weeks  - advanced to soft diet x1 week, then slowly introduce general foods  - Per GI recs: will need to maintain soft diet for at least 1 week, protonix 40mg BID x8 weeks, sucralfate 1g QID x4 weeks   Acute blood loss anemia due to upper GI bleed - stable over 7.  Monitor daily or as needed  - completed IV iron for 3 days.  Will discharge with daily iron  - during admission, required 6u prb, 1u FFP, 1u platelets   EKG, telemetry review - Telemetry is reading ""afib"" however on my personal review and formal EKG, rhythm is sinus with PAC.    Peripheral edema - due to aggressive fluid/blood repletion for hemorrhagic shock. Will continue HCTZ, encourage elevation. Can try compression stockings. Resolving traveler's diarrhea - resolved. Recently returned from over seas. More likely diarrhea was due to UGIB.  AKI - due to hypotension/hemorrhagic shock. - resolved.  HTN - PTA losartan, verapamil, HCTZ. Resumed COVID-19 - incidental positive. Asymptomatic. Patient fully vaccinated.  Today is 5th day of isolation.  Okay to be on public as long as he wears a mask starting tomorrow per CDC guidelines Hypothyroidism - continue Synthroid Hx Panic disorder - pta xanax prn"
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood pressure increased, Computerised tomogram thorax, Dyspnoea, Echocardiogram
Clinical narrative: First dose: about half a  hour after the administration I started to shake and my blood pressure rise a lot.  She was also short of breath.  Two days later she visited her cardiologist and the blood pressure was still high an she was retaining liquid, her legs was swollen.  Extreme tiredness and somnolence.  Second dose: Pain in the on the arm she was vaccinated.  The extreme tiredness and somnolence continued.  She also continue with the shortness of breath.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Fluid retention, Pain in extremity, Peripheral swelling
Clinical narrative: First dose: about half a  hour after the administration I started to shake and my blood pressure rise a lot.  She was also short of breath.  Two days later she visited her cardiologist and the blood pressure was still high an she was retaining liquid, her legs was swollen.  Extreme tiredness and somnolence.  Second dose: Pain in the on the arm she was vaccinated.  The extreme tiredness and somnolence continued.  She also continue with the shortness of breath.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Tremor
Clinical narrative: First dose: about half a  hour after the administration I started to shake and my blood pressure rise a lot.  She was also short of breath.  Two days later she visited her cardiologist and the blood pressure was still high an she was retaining liquid, her legs was swollen.  Extreme tiredness and somnolence.  Second dose: Pain in the on the arm she was vaccinated.  The extreme tiredness and somnolence continued.  She also continue with the shortness of breath.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia, Swelling
Clinical narrative: I had a fever that night and had a lot of swelling and joint pain.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Cardiac murmur, Cardiovascular evaluation, Condition aggravated, Echocardiogram
Clinical narrative: I had a heart murmur prior to being vaccinated, but it was louder after being vaccinated and I seem to be having a little more palpitations now. I just had a heart study and it showed that I have some Aarrhythmia's now that I don't believe I had before.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Electrocardiogram ambulatory, Palpitations
Clinical narrative: I had a heart murmur prior to being vaccinated, but it was louder after being vaccinated and I seem to be having a little more palpitations now. I just had a heart study and it showed that I have some Aarrhythmia's now that I don't believe I had before.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Acupuncture, Mobility decreased, Pain, Periarthritis, X-ray
Clinical narrative: Shoulder locked up. Movement became extremely painful and restricted. I was unable to lift my left arm above shoulder-level. Rotation limited to ~20 degrees off body center. I received acupuncture, followed by several weeks of physical therapy to loosen the joint.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event occurred. Recipient had received an initial dose of Janssen, a Janssen booster, and then a second Janssen booster--which is not approved by the CDC.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Slight fever, scratchy throat, running nose. COVID positive. Cough started later. They last about 2 weeks.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Slight fever, scratchy throat, running nose. COVID positive. Cough started later. They last about 2 weeks.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Anal incontinence, Asthenia, Blood creatinine increased, Brain natriuretic peptide increased
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Confusional state, Death, Decreased appetite
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fall, Fatigue, Gait inability, Glomerular filtration rate decreased
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Hypersomnia, Hypophagia, Hyporesponsive to stimuli, Lung opacity
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Nausea, Pleural effusion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Skin laceration, Unresponsive to stimuli
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 04/27/21, who admitted to the hospital with multiple complications including COVID and ultimately admitted to hospice services and died.  Provider discharge note to hospice services below:  "93 YO male that presented to the ED with c/o weakness, altered mental status, poor appetite, and fatigue. Chronic health conditions include pacemaker placement, HFrEF, AFib, CAD, COPD, HTN, and thyroid disease.  Patient was discharged from the hospital on December 9.  He began to seem symptomatic 3 days ago when he be became weak and had fatigue. Today he was found in his room confused, not knowing who his family members were and naked sitting in his own stool.  He had a fall in the last couple of days sustaining a head laceration.  He has become so weak that he cannot walk and he spends most of his day sleeping and not eating meals.  Patient relays that he has had a runny nose and nausea.  Patient denies chest pain or shortness of breath.    In the ED, HGB 11.5, creatinine 1.9 GFR 30, BNP 53,477, CXR shows hazy opacity throughout both lungs, and trace bilateral pleural effusions  COVID positive. (HPI per NP)   Hospital Course: No notes on file HFrEF  home medication includes Lasix 60 mg po daily. Start Lasix 60 IV BID. Strict I&O, daily weights. Fluid and sodium restrict. Repeat BNP Friday.    COVID patient has received his 1st 2 doses of COVID vaccine. Symptoms began 3 days ago. He is not hypoxic and is high risk for progression.    End of life care and placement patient has agreed due to his home circumstances and increasing need for more complicated care that he should accept placement to long-term care facility and would like hospice care as well.  Hospice consulted and family signed up for hospice. Patient remained very weak, dyspneic and debilitated and was admitted to GIP hospice.   Discharge Exam: General - very frail, debilitated, poorly responsive HEENT - NC AT Heart - S1 S2 RRR Lung - moderate air entry Neuro - Unresponsive     Issues Requiring Follow Up: (Who, what, when, and how communicated?) Admitted to GIP hospice"  Patient died on 01/03/22 on hospice services.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Immunosuppressant drug therapy, Sensory loss, Vertigo, Vestibular disorder
Clinical narrative: I had vertigo when I laid down on my back. That lasted about 30 second. These episodes would last for about 2 weeks then it went away. In late May 2021 when I got out of a car, I felt really unsteady on my feet. That would continue for about 3 months. I noticed I had a sensory loss from my feet up my calves. When I touch that part of my body the sensation was dull. I did see a doctor and they said it was a vestibular issue. This has been consistent up through March 2022 then it spread higher up to my knees. I did see a GI doctor and told him about the symptoms he advised a should see a neurologist. I am on a immunosuppressive drugs drug and he advised I should stop taking it. I'm still trying to find a neurologist.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Headache, Laboratory test, Lethargy
Clinical narrative: High ferritin level of 556.2 ng/ml  from acute-phase protein response to vaccine. Have been iron deficient since 2012. Get yearly infusion. Lab test on 4/15/22 and results on 4/22/22. Had headaches, lethargy, joint pain . Now lethargy. Have not been retested yet.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin increased
Clinical narrative: High ferritin level of 556.2 ng/ml  from acute-phase protein response to vaccine. Have been iron deficient since 2012. Get yearly infusion. Lab test on 4/15/22 and results on 4/22/22. Had headaches, lethargy, joint pain . Now lethargy. Have not been retested yet.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Starting 02/02/2022, I developed a rash on my left torso. It wasn't until 02/09/2022 that I saw my doctor via a telehealth visit who said it was shingles. There were medicines I could take, but due to it being a week after starting, I decided to let it run its course. It went away within a couple of weeks.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vision blurred
Clinical narrative: Patient states  at approximately 9pm on the evening of receiving her Pfizer Covid booster that she begin having blurry vision that lasted approximately 15 minutes. Patient also states that she began having left arm and leg numbness on the same evening. Patient states that the blurry vision resolved, but patient still have some numbness and tingling in the left arm and leg after 3 days.  Patient advised to contact PCP today about these issues as well.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received dose of covid vaccine which had been opened greater than 12 hours but less than 24 hours and contained at temperature less than room temperature. There was no immediate adverse reaction noted.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Skin warm
Clinical narrative: warm to touch, red, no pain or swelling-not restricting
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Aldolase, Anti-cyclic citrullinated peptide antibody, Antinuclear antibody, Arthralgia, Blood copper
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood folate, Blood iron, Blood magnesium, Blood potassium, Blood thyroid stimulating hormone
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood uric acid, C-reactive protein, Fatigue, Full blood count, Gastrooesophageal reflux disease
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin, HLA-B*27 assay, Immune-mediated adverse reaction, Iron binding capacity total, Lipids
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Metabolic function test, Psoriatic arthropathy, Red blood cell sedimentation rate, Rheumatoid factor
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin, Spinal X-ray, Thyroxine, Tinnitus, Tri-iodothyronine
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo, Vitamin B1, Vitamin B12, Vitamin D, X-ray
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray limb, X-ray limb abnormal
Clinical narrative: After the first dose I experienced normal immune reaction. After the second dose I experienced normal immune reaction but never really felt better. Beginning in mid-May I began experiencing extreme fatigue, increased symptoms of GERD, polyarthralgia (spine, hips, knees, ankles, feet), tinnitus, and vertigo. After ongoing symptoms for months I was referred to rheumatology and ultimately diagnosed with psoriatci arthritis  on Septemher 2021
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine administered was outside of use window. Vaccine had been opened 04/21/2022 at 0920. Vaccine administered to this patient on 04/22/2022 at 1440.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: patient tested positive for covid after exposure to daughter who had tested positive 4 days earlier
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Injection site swelling, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient came in post administration and said his arm was sore at the injection site and had some pins and needles feeling in him arm since the injection, however , he said it was slowly improving.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity, X-ray limb normal
Clinical narrative: Approximately 1 to 2 months after my vaccine I started having arthritis type sharp pain in both shoulders that increased over time. The pain has now increased to become a 8 out of 10 pain that radiates down my arms.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Electrocardiogram ambulatory, Heart rate increased, Pyrexia
Clinical narrative: After injection began experiencing rapid heart rate and just not feeling. Rapid heart rate lasted for 3 days. Also had fever and chills for 3 days. Was wearing a Holter monitor due to unrelated issues so events were recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received COVID vaccine which was considered expired as it exceeded the recommended expiration. The medication was kept at appropriate temp and minimal room temp exposure. There were no obvious side effects as a result of this.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Biopsy skin abnormal, Blister, Blood test, Dry skin
Clinical narrative: 06/30/2022 My skin was very dry and I had what I thought was acne or blisters on my back. It went on all summer and continued to get worse. In September, I began getting blisters on my stomach and I could not get dressed. I went to the dermatologist; they prescribed medications and could not figure out what it was. After a few months I was diagnosed with an autoimmune disease, Pemphigus Vulgaris.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Pemphigus, White blood cell count abnormal
Clinical narrative: 06/30/2022 My skin was very dry and I had what I thought was acne or blisters on my back. It went on all summer and continued to get worse. In September, I began getting blisters on my stomach and I could not get dressed. I went to the dermatologist; they prescribed medications and could not figure out what it was. After a few months I was diagnosed with an autoimmune disease, Pemphigus Vulgaris.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram pelvis abnormal, Nausea, Ovarian cyst ruptured, Pain, Vomiting
Clinical narrative: Like a couple months after the shot, I started having pain, like very strange pain like nauseous like wanting to throw up. I did not do anything and it went away. It came again in October and in November I threw up while I was driving so I went to the hospital. The hospital CT scan. It showed I had an erupted ovarian cyst. They told me if there was any fever, I would have to have surgery to remove the cyst. I did not need surgery. The hospital told me to follow up with a gynecologist. I found an gynecologist that took my insurance, I was told that it was side effect from the vaccine.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Amnesia, Asthma, Blood test, Chest X-ray
Clinical narrative: I had pain at the vaccination site with swelling and redness in my arm. I was fatigued, nauseous, headache, chills, and body aches. For about a day and a half. No immediate symptoms that were coming on other than these listed. I have been having brain fog and memory loss, as well as smell training as well. I have no sense of taste back either, and I still continue to have severe body aches, muscle fatigue and cramping and spasming. I came down with covid-19 January 2nd 2021. I don't feel like I have gotten better since having covid-19. I am currently seeing a team of professionals at the covid clinic program where they are introducing new ways to regain my smell, and working with them on my mental state with brain fog and memory loss. I also use a CPAP machine and asthma has become very aggravated as well. I also have developed a cough that causes a lot of pain as well. I did go to the emergency room in February 2022 due to edema in my left leg and my knee had a strange spot and wanted to make sure that I did not have any blood clots which were ruled out by ultrasound.